Home › Amyloidosis › Indiana › Indianapolis
Amyloidosis clinical trials in Indianapolis, IN
3 studies for Amyloidosis are looking for participants at sites in and around Indianapolis (within about 30 miles). Open a study to see who can join and how to contact the study team.
Non-interventional Study of Patients With Transthyretin (ATTR) Amyloidosis
RecruitingObservational study
- Research Site, Indianapolis
TRITON-CM: A Study to Evaluate Nucresiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy
RecruitingPhase 3
- Clinical Trial Site, Indianapolis
- Clinical Trial Site, Indianapolis
MAGNITUDE: A Phase 3 Study of NTLA-2001 in Participants With Transthyretin Amyloidosis With Cardiomyopathy (ATTR-CM)
RecruitingPhase 3
- Indiana University Health, Indianapolis
About Amyloidosis
Amyloidosis is a rare condition that can affect different organs of the body. Find out about amyloidosis treatment and symptoms.
More about Amyloidosis on MedlinePlus
Amyloidosis trials in other cities
- Boston, MA11 studies
- Rochester, MN10 studies
- New York City, NY10 studies
- Dallas, TX9 studies
- Philadelphia, PA7 studies
- St. Louis, MO6 studies
- Houston, TX6 studies
- Baltimore, MD6 studies
- Durham, NC6 studies
- Portland, OR6 studies
- Washington, DC5 studies
- San Diego, CA5 studies
Other studies in Indianapolis
- Non-Small Cell Lung Cancer32 studies
- Cancer (all types)25 studies
- Heart Failure23 studies
- Obesity20 studies
- Breast Cancer20 studies
- Metastatic Cancer19 studies
- Colorectal Cancer18 studies
- Ovarian Cancer17 studies
- Cardiovascular Disease16 studies
- Lung Cancer16 studies
- Endometrial Cancer15 studies
- Alzheimer's Disease14 studies
From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.